A cis-acting regulatory variant in the IL2RA locus

Journal of Immunology

Volumn 183, Issue 8, 2009, Pages 5158-5162

  Qu, Hui Qi ^a   Verlaan, Dominique J ^b   Ge, Bing ^b   Lu, Yang ^a   Lam, Kevin C L ^b   Grabs, Rosemarie ^a   Harmsen, Eef ^b   Hudson, Thomas J ^c   Hakonarson, Hakon ^d   Pastinen, Tomi ^b   Polychronakos, Constantin ^a  

^a MONTREAL CHILDREN S HOSPITAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIS ACTING ELEMENT; INTERLEUKIN 2 RECEPTOR ALPHA; RNA;

ARTICLE; GENE LINKAGE DISEQUILIBRIUM; GENE MAPPING; HAPLOTYPE; HETEROZYGOSITY; LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; DIABETES MELLITUS, TYPE 1; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LINKAGE DISEQUILIBRIUM; POLYMORPHISM, SINGLE NUCLEOTIDE; T-LYMPHOCYTE SUBSETS;

EID: 77954134112     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0901337     Document Type: Article

References (20)

1. + regulatory T cells and their therapeutic potential. Annu. Rev. Med. 57: 381-402.
2. Willerford, D. M., J. Chen, J. A. Ferry, L. Davidson, A. Ma, and F. W. Alt. 1995. Interleukin-2 receptor α chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3: 521.
3. Vella, A., J. D. Cooper, C. E. Lowe, N. Walker, S. Nutland, B. Widmer, R. Jones, S. M. Ring, W. McArdle, M. E. Pembrey, et al. 2005. Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms. Am. J. Hum. Genet. 76: 773-779.
4. Lowe, C. E., J. D. Cooper, T. Brusko, N. M. Walker, D. J. Smyth, R. Bailey, K. Bourget, V. Plagnol, S. Field, M. Atkinson, et al. 2007. Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes. Nat. Genet. 39: 1074-1082.
5. Qu, H.-Q., A. Montpetit, B. Ge, T. J. Hudson, and C. Polychronakos. 2007. Toward further mapping of the association between the IL2RA locus and type 1 diabetes. Diabetes 56: 1174-1176.
6. Weber, F., B. Fontaine, I. Cournu-Rebeix, A. Kroner, M. Knop, S. Lutz, F. Muller-Sarnowski, M. Uhr, T. Bettecken, M. Kohli, et al. 2008. IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populations. Genes Immun. 9: 259-263.
7. Maier, L. M., C. E. Lowe, J. Cooper, K. Downes, D. E. Anderson, C. Severson, P. M. Clark, B. Healy, N. Walker, C. Aubin, et al. 2009. IL2RA genetic heterogeneity in multiple sclerosis and type 1 diabetes susceptibility and soluble interleukin-2 receptor production. PLoS Genetics 5: e1000322.
8. Alcina, A., M. Fedetz, D. Ndagire, O. Fernandez, L. Leyva, M. Guerrero, M. M. Abad-Grau, C. Arnal, C. Delgado, M. Lucas, et al. 2009. IL2RA/CD25 gene polymorphisms: uneven association with multiple sclerosis (MS) and type 1 diabetes (T1D). PLoS ONE 4: e4137.
9. Hinks, A., X. Ke, A. Barton, S. Eyre, J. Bowes, J. Worthington, S. D. Thompson, C. D. Langefeld, D. N. Glass, and W. Thomson. 2009. Association of the IL2RA/CD25 gene with juvenile idiopathic arthritis. Arthritis Rheum. 60: 251-257.
10. Nejentsev, S., N. Walker, D. Riches, M. Egholm, and J. A. Todd. 2009. Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science 324: 387-389.
11. Verlaan, D. J., B. Ge, E. Grundberg, R. Hoberman, K. C. Lam, V. Koka, J. Dias, S. Gurd, N. W. Martin, H. Mallmin, et al. 2009. Targeted screening of cisregulatory variation in human haplotypes. Genome Res. 19: 118-127.
12. Pastinen, T., B. Ge, S. Gurd, T. Gaudin, C. Dore, M. Lemire, P. Lepage, E. Harmsen, and T. J. Hudson. 2005. Mapping common regulatory variants to human haplotypes. Hum. Mol. Genet. 14: 3963-3971.
13. Koeleman, B. P. C., F. Dudbridge, H. J. Cordell, and J. A. Todd. 2000. Adaptation of the extended transmission/disequilibrium test to distinguish disease associations of multiple loci: the Conditional Extended Transmission/Disequilibrium Test. Ann. Hum. Genet. 64: 207-213.
14. Dudbridge, F. 2003. Pedigree disequilibrium tests for multilocus haplotypes. Genet. Epidemiol. 25: 115-121.
15. Gimelbrant, A., J. N. Hutchinson, B. R. Thompson, and A. Chess. 2007. Widespread monoallelic expression on human autosomes. Science 318: 1136-1140.
16. Choy, E., R. Yelensky, S. Bonakdar, R. M. Plenge, R. Saxena, P. L. De Jager, S. Y. Shaw, C. S. Wolfish, J. M. Slavik, C. Cotsapas, et al. 2008. Genetic analysis of human traits in vitro: drug response and gene expression in lymphoblastoid cell lines. PLoS Genet 4: e1000287.
17. Yamanouchi, J., D. Rainbow, P. Serra, S. Howlett, K. Hunter, V. E. Garner, A. Gonzalez-Munoz, J. Clark, R. Veijola, R. Cubbon, et al. 2007. Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity. Nat. Genet. 39: 329-337.
18. + suppressor T cells. J. Exp. Med. 193: F41-F46.
19. + regulatory T lymphocytes in neonatal NOD mice. Ann. NY. Acad. Sci. 1051: 72-87.
20. Rabinovitch, A., W. L. Suarez-Pinzon, A. M. Shapiro, R. V. Rajotte, and R. Power. 2002. Combination therapy with sirolimus and interleukin-2 prevents spontaneous and recurrent autoimmune diabetes in NOD mice. Diabetes 51: 638-645. (Pubitemid 34760170)